Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    INDIUM IN-111 PENTETREOTIDE KIT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 159201-00-0, Indium in 111 pentetreotide [usan], 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+), Octreoscan (tn), Indium in 111 pentetreotide (usp), Indate(1-), (n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-n-(carboxymethyl)glycyl-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamide cyclic (3-8)-disulfidato(4-))-, hydrogen, (r-(r*,r*))-
    Molecular Formula
    C63H84InN13O19S2
    Molecular Weight
    1506.4  g/mol
    InChI Key
    ONJXCGCIKIYAPL-UHFFFAOYSA-K
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)
    2.1.2 InChI
    InChI=1S/C63H87N13O19S2.In/c1-37(78)48(34-77)70-62(94)50-36-97-96-35-49(71-58(90)45(25-39-13-5-3-6-14-39)66-51(80)29-75(31-53(83)84)23-21-74(30-52(81)82)22-24-76(32-54(85)86)33-55(87)88)61(93)68-46(26-40-15-7-4-8-16-40)59(91)69-47(27-41-28-65-43-18-10-9-17-42(41)43)60(92)67-44(19-11-12-20-64)57(89)73-56(38(2)79)63(95)72-50;/h3-10,13-18,28,37-38,44-50,56,65,77-79H,11-12,19-27,29-36,64H2,1-2H3,(H,66,80)(H,67,92)(H,68,93)(H,69,91)(H,70,94)(H,71,90)(H,72,95)(H,73,89)(H,81,82)(H,83,84)(H,85,86)(H,87,88);/q;+3/p-3
    2.1.3 InChI Key
    ONJXCGCIKIYAPL-UHFFFAOYSA-K
    2.1.4 Canonical SMILES
    [H+].CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(CO)C(C)O)O.[In+3]
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. 111 In -pentetreotide

    2. 111-indium-pentetreotide

    3. In-111 Pentetreotide

    4. Indium Ln-111 Pentetreotide

    5. Indium-pentetreotide

    6. Octreoscan

    7. Octreoscan 111

    8. Pentetreotide

    2.2.2 Depositor-Supplied Synonyms

    1. 159201-00-0

    2. Indium In 111 Pentetreotide [usan]

    3. 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)

    4. Octreoscan (tn)

    5. Indium In 111 Pentetreotide (usp)

    6. Indate(1-), (n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-n-(carboxymethyl)glycyl-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamide Cyclic (3-8)-disulfidato(4-))-, Hydrogen, (r-(r*,r*))-

    7. 139096-04-1

    8. D02108

    2.3 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 1506.4 g/mol
    Molecular Formula C63H84InN13O19S2
    Hydrogen Bond Donor Count14
    Hydrogen Bond Acceptor Count25
    Rotatable Bond Count30
    Exact Mass1505.4486636 g/mol
    Monoisotopic Mass1505.4486636 g/mol
    Topological Polar Surface Area556 Ų
    Heavy Atom Count98
    Formal Charge0
    Complexity2570
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count10
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameOctreoscan
    PubMed HealthIndium In 111 Pentetreotide (Injection)
    Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
    Active IngredientIndium in-111 pentetreotide kit
    Dosage FormInjectable
    RouteInjection
    Strength3mci/ml
    Market StatusPrescription
    CompanyMallinckrodt

    2 of 2  
    Drug NameOctreoscan
    PubMed HealthIndium In 111 Pentetreotide (Injection)
    Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
    Active IngredientIndium in-111 pentetreotide kit
    Dosage FormInjectable
    RouteInjection
    Strength3mci/ml
    Market StatusPrescription
    CompanyMallinckrodt